Genetic variation of HIV type 1: relevance of interclade variation to vaccine development.
about
T-helper-cell proliferative responses to whole-killed human immunodeficiency virus type 1 (HIV-1) and p24 antigens of different clades in HIV-1-infected subjects vaccinated with HIV-1 immunogen (Remune)Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa.HIV-1 subtype A infection in a community of intravenous drug users in Pakistan.Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelityNeutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.Phylogenetic analysis of the p24-p7 region of the human immunodeficiency virus type 1 gag gene to determine subtype distribution among female sex workers in Calcutta, India.Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa.Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy AdultsImmunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.Mutations in the RNase H primer grip domain of murine leukemia virus reverse transcriptase decrease efficiency and accuracy of plus-strand DNA transfer.Human immunodeficiency virus type 1 primary isolate neutralization resistance is associated with the syncytium-inducing phenotype and lower CD4 cell counts in subtype CRF01_AE-infected patients.Immunogenicity of the outer domain of a HIV-1 clade C gp120.
P2860
Q30327166-66A545CB-96BF-4DEE-A2C4-5CA7294188DEQ30327384-6A1B430E-8FAC-414D-BD1E-93A00ADDDE64Q33263602-3D2155D8-26BF-4069-9E38-7E6FB88575FEQ33794922-16EB08F2-6EC6-4DA1-A5C1-983B80C4FBEEQ34085098-6C51510B-D1D8-4CAA-8E60-22B97FCE04A7Q34143771-F29B0AE8-4326-43AA-B2C0-CB092869030EQ34229329-4ED1CAC1-E0C0-452C-94DA-7FBDC1BA0844Q36172965-E80338DF-668B-4AE1-AE09-82DCD992279AQ37059723-3DF2A357-0CA5-494C-BC0A-4209FA125A3CQ37747347-0B1FEE15-CC41-45C1-8EAB-2F439FFE2A4BQ39789278-57731B2F-C5CE-4CDE-9180-8AB700C0D1DDQ41961460-6CE66568-5775-45A1-8A95-E26A0F2E9809
P2860
Genetic variation of HIV type 1: relevance of interclade variation to vaccine development.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Genetic variation of HIV type ...... iation to vaccine development.
@en
Genetic variation of HIV type ...... iation to vaccine development.
@nl
type
label
Genetic variation of HIV type ...... iation to vaccine development.
@en
Genetic variation of HIV type ...... iation to vaccine development.
@nl
prefLabel
Genetic variation of HIV type ...... iation to vaccine development.
@en
Genetic variation of HIV type ...... iation to vaccine development.
@nl
P2093
P1476
Genetic variation of HIV type 1: relevance of interclade variation to vaccine development
@en
P2093
Beirnaert E
Heyndrickx L
Janssens W
Van der Auwera G
van der Groen G
P304
P478
14 Suppl 3
P50
P577
1998-10-01T00:00:00Z